Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07035964 · ClinicalTrials.gov registry record · NA
Effects of Effera Human Lactoferrin at One Dose Compared to Placebo on Gut Permeability
A NA study of Gut Health and Gut Permeability, sponsored by Helaina.
- Recruiting
- Registry status
- NA
- Development phase
- 46
- Enrollment target
- 1
- Study location
NCT07035964 is a NA study of Gut Health and Gut Permeability that is actively recruiting participants, run by Helaina. The registered enrollment target is 46 participants, below the 57-participant average among 9 other Gut Health trials with a reported enrollment target (19% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07035964, a NA study of Gut Health and Gut Permeability, is actively recruiting participants, sponsored by Helaina.
- RECRUITING
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the impact of 28-day supplementation with effera human lactoferrin, compared to a placebo control product on indicators of gut barrier health in males and females
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT human lactoferrin
Study Locations (1)
Illinois
- Biofortis Inc - Addison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2025-06-04 |
| Est. Completion | 2025-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07035964
The ClinicalTrials.gov registry entry for NCT07035964 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 57-participant average among 9 other Gut Health trials with a reported enrollment target (19% lower). The listed sponsor is Helaina, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Gut Health appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT07035964 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT07035964 about?
NCT07035964 is a clinical study titled "Effects of Effera Human Lactoferrin at One Dose Compared to Placebo on Gut Permeability". The purpose of this study is to evaluate the impact of 28-day supplementation with effera human lactoferrin, compared to a placebo control product on indicators of gut barrier health in males and females
What is the current status of trial NCT07035964?
This trial is currently recruiting. It is a NA study. The enrollment target is 46 participants. The study started on 2025-06-04. Estimated completion is 2025-08-30.
What conditions does trial NCT07035964 study?
This clinical trial studies the following conditions: Gut Health, Gut Permeability.
What interventions are being tested in trial NCT07035964?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), human lactoferrin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07035964?
This trial is sponsored by Helaina, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07035964 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gut Health
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of B. Adolescentis iVS-1 Probiotic on Gastrointestinal Outcomes
RECRUITING · NA
-
An 8-Week Study Evaluating Gut and Digestive Health After Use of a Dietary Supplement System
RECRUITING · NA
-
The Effect Cranberry-Based Products on the Female Microbiome
RECRUITING · NA
-
Impact of Weizmannia (Bacillus) Coagulans JBI-YZ6.3 on Gut Health and Fecal Microbiome Changes
RECRUITING · NA
-
A Study to Evaluate the Effects of a Butyrate-Polyphenol Formulation on Gut Health and Associated Symptoms
RECRUITING · NA
-
Cardiometabolic Benefits of Potatoes Mediated Along the Gut-Vessel Axis in Adults With Metabolic Syndrome
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.